Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seaman

Showing results (131-140 of 415) with videos related to

Pageof 42
Sort By:
Vaccine|March 21, 2020
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticityJennifer I Lai, Susan K Eszterhas, Seth A Brooks, et al.
BMC Immunology|May 31, 2011
LabKey Server NAb: a tool for analyzing, visualizing and sharing results from neutralizing antibody assaysBritt Piehler, Elizabeth K Nelson, Josh Eckels, et al.
The Journal of Experimental Medicine|April 13, 2019
HIV-specific humoral immune responses by CRISPR/Cas9-edited B cellsHarald Hartweger, Andrew T McGuire, Marcel Horning, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Virology|September 16, 2016
Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001Matthew R Costa, Justin Pollara, Regina Whitney Edwards, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Antibodies (Basel, Switzerland)|August 6, 2020
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous AdministrationVaneet K Sharma, Bijay Misra, Kevin T McManus, et al.
Journal of Virology|January 20, 2012
HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopesNicole A Doria-Rose, Mark K Louder, Zhongjia Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
Plos Pathogens|July 7, 2011
Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivityHillel Haim, Bettina Strack, Aemro Kassa, et al.
Pageof 42

Showing results (131-140 of 415) with videos related to

Sort By:
Pageof 42
Vaccine|March 21, 2020
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticityJennifer I Lai, Susan K Eszterhas, Seth A Brooks, et al.
BMC Immunology|May 31, 2011
LabKey Server NAb: a tool for analyzing, visualizing and sharing results from neutralizing antibody assaysBritt Piehler, Elizabeth K Nelson, Josh Eckels, et al.
The Journal of Experimental Medicine|April 13, 2019
HIV-specific humoral immune responses by CRISPR/Cas9-edited B cellsHarald Hartweger, Andrew T McGuire, Marcel Horning, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Virology|September 16, 2016
Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001Matthew R Costa, Justin Pollara, Regina Whitney Edwards, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Antibodies (Basel, Switzerland)|August 6, 2020
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous AdministrationVaneet K Sharma, Bijay Misra, Kevin T McManus, et al.
Journal of Virology|January 20, 2012
HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopesNicole A Doria-Rose, Mark K Louder, Zhongjia Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
Plos Pathogens|July 7, 2011
Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivityHillel Haim, Bettina Strack, Aemro Kassa, et al.
Pageof 42